Patient is a child who has cgvhd following bone marrow transplant for scid.He has haemolysis, which the team thinks is due to early withdrawal of steroids.Despite rbc transfusion his hemoglobin drops.It is currently running around 6g/dl, with a hct in the low 20s.They have commenced retuximab and will rest him this week from ecp.He is given some return volume at the end of treatment to raise hb and avoid excessive donor exposures.(but fe is of course also very elevated).It was reported that they haven't had any problem with the actual ecp procedure, but are wondering if anyone else has any experienced with this king of situation and patient and if it's okay to continue.The customer asserts the that hemolysis is not connected to the ecp treatment and no extra transfusion support was needed following this treatment.Patient was reported to be in stable condition.Medical affairs department responded to the customer.No product was returned for investigation.
|
No kit lot number was reported; therefore, no batch record review was performed.Trends were reviewed for complaint category, hemolysis and no trends were detected.This assessment is based on information available at the time of this report.No product was returned for evaluation; therefore, it could not be determined if this specific product met specifications.
|